Sodium iodide symporter-targeted gene therapy in glioblastoma

• Juan Pablo Nicola,
• Christopher J. LaRocca

Affiliations

Juan Pablo Nicola

Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba, Argentina; Clinical Biochemistry and Immunology Research Center - National Scientific and Technical Research Council (CIBICI-CONICET), Córdoba, Argentina; Corresponding author: Juan Pablo Nicola, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba, Argentina.

Christopher J. LaRocca

Department of Surgery, Division of Surgical Oncology, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Corresponding author: Christopher J. LaRocca, Department of Surgery, Division of Surgical Oncology, University of Minnesota, Minneapolis, MN, USA.